Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ARV DRUG RESISTANCE MUTATIONS AMONG A6 SUBTYPE PLWH IN KAZAKHSTAN.

Georgian medical news - 1 Feb 2022

Nurzhigitov N, Sanaubarova A, Nugmanova Zh, Ali S, Akbay B

Abstract excerpt

The Department of Health and Human Services and the World Health Organization (WHO) have established HIV regimens that include a variety of antiretroviral therapy (ART) medications for the treatment of HIV infected people. The Ministry of Health in Kazakhstan has authorized a clinical protocol (№97, 11.06.2020) for HIV treatment in accordance with WHO recommendations. For HIV treatment two types of ARV cocktails...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Resistance
Share to HIV-1
Share to HIV Infections

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Kazakhstan

Share to Mutation

Share to United States

Source

Identifiers

PMID: 35271476

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ARV DRUG RESISTANCE MUTATIONS AMONG A6 SUBTYPE PLWH IN KAZAKHSTAN.PMID 35271476Read ↗

High-Level Drug-Resistant Mutations among HIV-1 Subtype A6 and CRF02_AG in Kazakhstan.Semantic proximity Read ↗

Antiretroviral therapy resistance mutations among HIV infected people in Kazakhstan.Semantic proximity Read ↗

HIV-1 Drug Resistance among Treatment-Naïve Patients in Russia: Analysis of the National Database, 2006-2022.Semantic proximity Read ↗

HIV-1 Sub-Subtype A6: Settings for Normalised Identification and Molecular Epidemiology in the Southern Federal District, Russia.Semantic proximity Read ↗

Prevalence of Antiretroviral Drug Resistance Mutations Among Pretreatment and Antiretroviral Therapy-Failure HIV Patients in Uzbekistan.Semantic proximity Read ↗

HIV-1 subtypes distribution and resistance to ART in HIV-infected persons in Slovakia (2019-2021).Semantic proximity Read ↗

Genetic Diversity and Drug Resistance Mutations in Reverse Transcriptase and Protease Genes of HIV-1 Isolates from Southwestern Siberia.Semantic proximity Read ↗

Emerging Trends in HIV-1 Sub-Subtype A6 in Belgium: Transmission Dynamics, Drug Resistance, and Subtyping Tool Evaluation.Semantic proximity Read ↗

Drug Resistance Mutations (DRMs) for Long-Acting Injectable Cabotegravir and Rilpivirine (CAB/RPV LAI) in the HIV-1 Subtype A6 Epidemic in PolandSemantic proximity Read ↗

Characterization of HIV-1 subtypes and drug resistance mutations in Slovakia: update 2017-2018.Semantic proximity Read ↗

Distinct Molecular Epidemiology, Transmission Patterns, and Resistance Mutations of HIV-1 Subtypes A1, A6, and A7 in BulgariaSemantic proximity Read ↗

HIV drug resistance among patients experiencing antiretroviral therapy failure in Russia, 2019-2021.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.